123 related articles for article (PubMed ID: 38360210)
1. Significance Associated with Phenotype Score Aids in Variant Prioritization for Exome Sequencing Analysis.
Lee B; Nasanovsky L; Shen L; Maglinte DT; Pan Y; Gai X; Schmidt RJ; Raca G; Biegel JA; Roytman M; An P; Saunders CJ; Farrow EG; Shams S; Ji J
J Mol Diagn; 2024 May; 26(5):337-348. PubMed ID: 38360210
[TBL] [Abstract][Full Text] [Related]
2. An Improved Phenotype-Driven Tool for Rare Mendelian Variant Prioritization: Benchmarking Exomiser on Real Patient Whole-Exome Data.
Cipriani V; Pontikos N; Arno G; Sergouniotis PI; Lenassi E; Thawong P; Danis D; Michaelides M; Webster AR; Moore AT; Robinson PN; Jacobsen JOB; Smedley D
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32340307
[TBL] [Abstract][Full Text] [Related]
3. Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder.
Thompson R; Papakonstantinou Ntalis A; Beltran S; Töpf A; de Paula Estephan E; Polavarapu K; 't Hoen PAC; Missier P; Lochmüller H
Hum Mutat; 2019 Oct; 40(10):1797-1812. PubMed ID: 31231902
[TBL] [Abstract][Full Text] [Related]
4. Computational evaluation of exome sequence data using human and model organism phenotypes improves diagnostic efficiency.
Bone WP; Washington NL; Buske OJ; Adams DR; Davis J; Draper D; Flynn ED; Girdea M; Godfrey R; Golas G; Groden C; Jacobsen J; Köhler S; Lee EM; Links AE; Markello TC; Mungall CJ; Nehrebecky M; Robinson PN; Sincan M; Soldatos AG; Tifft CJ; Toro C; Trang H; Valkanas E; Vasilevsky N; Wahl C; Wolfe LA; Boerkoel CF; Brudno M; Haendel MA; Gahl WA; Smedley D
Genet Med; 2016 Jun; 18(6):608-17. PubMed ID: 26562225
[TBL] [Abstract][Full Text] [Related]
5. A pipeline combining multiple strategies for prioritizing heterozygous variants for the identification of candidate genes in exome datasets.
Requena T; Gallego-Martinez A; Lopez-Escamez JA
Hum Genomics; 2017 May; 11(1):11. PubMed ID: 28532469
[TBL] [Abstract][Full Text] [Related]
6. Prioritization of oligogenic variant combinations in whole exomes.
Gravel B; Renaux A; Papadimitriou S; Smits G; Nowé A; Lenaerts T
Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38603604
[TBL] [Abstract][Full Text] [Related]
7. Rapid and accurate interpretation of clinical exomes using Phenoxome: a computational phenotype-driven approach.
Wu C; Devkota B; Evans P; Zhao X; Baker SW; Niazi R; Cao K; Gonzalez MA; Jayaraman P; Conlin LK; Krock BL; Deardorff MA; Spinner NB; Krantz ID; Santani AB; Tayoun ANA; Sarmady M
Eur J Hum Genet; 2019 Apr; 27(4):612-620. PubMed ID: 30626929
[TBL] [Abstract][Full Text] [Related]
8. Improved exome prioritization of disease genes through cross-species phenotype comparison.
Robinson PN; Köhler S; Oellrich A; ; Wang K; Mungall CJ; Lewis SE; Washington N; Bauer S; Seelow D; Krawitz P; Gilissen C; Haendel M; Smedley D
Genome Res; 2014 Feb; 24(2):340-8. PubMed ID: 24162188
[TBL] [Abstract][Full Text] [Related]
9. Population Prevalence of Deleterious
LeDoux MS
Tremor Other Hyperkinet Mov (N Y); 2020 Nov; 10():50. PubMed ID: 33200041
[TBL] [Abstract][Full Text] [Related]
10. A clinically driven variant prioritization framework outperforms purely computational approaches for the diagnostic analysis of singleton WES data.
Stark Z; Dashnow H; Lunke S; Tan TY; Yeung A; Sadedin S; Thorne N; Macciocca I; Gaff C; ; Oshlack A; White SM; James PA
Eur J Hum Genet; 2017 Nov; 25(11):1268-1272. PubMed ID: 28832562
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
Seo GH; Kim T; Choi IH; Park JY; Lee J; Kim S; Won DG; Oh A; Lee Y; Choi J; Lee H; Kang HG; Cho HY; Cho MH; Kim YJ; Yoon YH; Eun BL; Desnick RJ; Keum C; Lee BH
Clin Genet; 2020 Dec; 98(6):562-570. PubMed ID: 32901917
[TBL] [Abstract][Full Text] [Related]
12. Analysis of laboratory reporting practices using a quality assessment of a virtual patient.
Vears DF; Elferink M; Kriek M; Borry P; van Gassen KL
Genet Med; 2021 Mar; 23(3):562-570. PubMed ID: 33122805
[TBL] [Abstract][Full Text] [Related]
13. Evaluating phenotype-driven approaches for genetic diagnoses from exomes in a clinical setting.
Pengelly RJ; Alom T; Zhang Z; Hunt D; Ennis S; Collins A
Sci Rep; 2017 Oct; 7(1):13509. PubMed ID: 29044180
[TBL] [Abstract][Full Text] [Related]
14. A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics.
James RA; Campbell IM; Chen ES; Boone PM; Rao MA; Bainbridge MN; Lupski JR; Yang Y; Eng CM; Posey JE; Shaw CA
Genome Med; 2016 Feb; 8(1):13. PubMed ID: 26838676
[TBL] [Abstract][Full Text] [Related]
15. Disease insights through cross-species phenotype comparisons.
Haendel MA; Vasilevsky N; Brush M; Hochheiser HS; Jacobsen J; Oellrich A; Mungall CJ; Washington N; Köhler S; Lewis SE; Robinson PN; Smedley D
Mamm Genome; 2015 Oct; 26(9-10):548-55. PubMed ID: 26092691
[TBL] [Abstract][Full Text] [Related]
16. Improving variant prioritization in exome analysis by entropy-weighted ensemble of multiple tools.
Fan Y; Zhou Y; Liu H; Luo X; Xu T; Sun Y; Yang T; Chen L; Gu X; Yu Y
Clin Genet; 2023 Feb; 103(2):190-199. PubMed ID: 36309956
[TBL] [Abstract][Full Text] [Related]
17. GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data.
Mossotto E; Ashton JJ; O'Gorman L; Pengelly RJ; Beattie RM; MacArthur BD; Ennis S
BMC Bioinformatics; 2019 May; 20(1):254. PubMed ID: 31096927
[TBL] [Abstract][Full Text] [Related]
18. Identifying Mendelian disease genes with the variant effect scoring tool.
Carter H; Douville C; Stenson PD; Cooper DN; Karchin R
BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S3. PubMed ID: 23819870
[TBL] [Abstract][Full Text] [Related]
19. DeepPVP: phenotype-based prioritization of causative variants using deep learning.
Boudellioua I; Kulmanov M; Schofield PN; Gkoutos GV; Hoehndorf R
BMC Bioinformatics; 2019 Feb; 20(1):65. PubMed ID: 30727941
[TBL] [Abstract][Full Text] [Related]
20. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases.
Salfati EL; Spencer EG; Topol SE; Muse ED; Rueda M; Lucas JR; Wagner GN; Campman S; Topol EJ; Torkamani A
Genome Med; 2019 Dec; 11(1):83. PubMed ID: 31847883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
